e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Childhood tuberculosis: progress requires an advocacy strategy now
Sandgren Andreas, Cuevas Luis E., Dara Masoud, Gie Robert P., Grzemska Malgorzata, Hawkridge Anthony, Hesseling Anneke C., Kampmann Beate, Lienhardt Christian, Manissero Davide, Wingfield Claire, Graham Stephen M.
Source:
Eur Respir J 2012; 40: 294-297
Journal Issue:
August
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sandgren Andreas, Cuevas Luis E., Dara Masoud, Gie Robert P., Grzemska Malgorzata, Hawkridge Anthony, Hesseling Anneke C., Kampmann Beate, Lienhardt Christian, Manissero Davide, Wingfield Claire, Graham Stephen M.. Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J 2012; 40: 294-297
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Evaluation of a large-scale tuberculosis contact investigation in the Netherlands
Source: Eur Respir J 2008; 32: 419-425
Year: 2008
Knowledge and attitude about tuberculosis disease in a health workers population
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement
Source: Eur Respir J 2012; 40: 1081-1090
Year: 2012
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?
Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017
Year: 2017
Increased incidence of TB disease within the health-care workers in an intermediate TB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Tuberculosis control program in public health system (family health units) in São Luis-MA-Brazil: patients profiles and compliance
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006
The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results
Source: Eur Respir J 2011; 38: 1374-1381
Year: 2011
Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice
Source: Eur Respir J 2011; 37: 1175-1182
Year: 2011
European framework to decrease the burden of TB/HIV
Source: Eur Respir J 2004; 24: 493-501
Year: 2004
Prevalence of latent tuberculosis infection among household contacts and community controls in South India
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Active case-finding of tuberculosis in Europe
Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis
Year: 2007
Protection of healthcare workers against transmission of
Mycobacterium tuberculosis
in hospitals: a review of the evidence
Source: ERJ Open Res, 6 (1) 00317-2019; 10.1183/23120541.00317-2019
Year: 2020
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Source: Eur Respir J 2011; 38: 516-528
Year: 2011
Tuberculosis causes poverty but do tuberculosis control programmes reach the poor?
Source: Annual Congress 2004 - Risks for tuberculosis
Year: 2004
The European union standards for tuberculosis care: Do they need an update?
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept